Vincent Gruntz
Chief Executive Officer (CEO)
Enabling clinical cancer research for a cure tomorrow by unleashing the combined power of all our teams.
Leader who inspires teams with a vision and achieves outstanding business results.
Broadly networked within the Swiss healthcare system, with in-depth knowledge of international healthcare systems. Raised bilingually (German/French) with excellent English skills, recognized coach with a passion for developing team potential.
Personal leadership vision is based on “Appreciation, Innovation, and Responsibility.”
Career
- Sept. 2024 - Present: Chief Executive Officer (CEO), Swiss Cancer Institute
- Oct. 2023 - Sept. 2024: Vice President International Head of Cell and Gene Therapies, Novartis
- Oct 22 - Oct 23: Vice President International Head of Therapeutic Area Neuroscience, Novartis
- Oct 2019 - Sep 2022: General Manager (CEO) Oncology Schweiz, Novartis
- May 2017 - Sep 2019: Commercial Executive Director Cardiology (a.i. Chief Commercial Officer) Europe, Novartis
- July 2015 - April 2017: Patient Access Director Neuroscience & Optha, Europe, Novartis
- Mai 2013 - June 2015: Business Unit Director Diabetes Austria and Switzerland, Eli Lilly
- Nov 2010 - April 2013: Corporate Affairs Director Austria and Switzerland
- June 2005 - Feb. 2008: Manager Access, Public Affairs & BD&L, Novartis
- June 2005 - Feb. 2008: Economist, Federal Office of Public Health
Education
lic. rer. pol. University of Basel
Membership
- ASCO American Society of Clinical Oncology
- Board Member CareKöniz
Languages
- German
- French
- English